Andrew Obenshain - President and CEO, Director at bluebird bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
BLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Andrew Obenshain - trading volume in the past year for bluebird bio, Inc.

Holdings reported by Andrew Obenshain for bluebird bio, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 279,998 $428 K $1.53 Mar 4, 2024 Direct
Stock Option (right to buy) 650,000 Mar 1, 2024 Direct Common Stock

Transactions reported by Andrew Obenshain for bluebird bio, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership